MedTrace Logo

Adolescent SCreening To Help Eliminate Misuse

NCT04200339 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 810

Last updated 2022-03-18

No results posted yet for this study

Summary

The specific aim of this study is to evaluate the performance of three substance use screening instruments (S2BI, BSTAD, and TAPS Tool) against a criterion standard of Diagnostic Statistical Manual - 5 (DSM-5) substance use disorder (SUD) diagnoses in an adolescent population.

Conditions

  • Substance Use

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • The Emmes Company, LLC

    collaborator INDUSTRY

  • Friends Research Institute, Inc.

    collaborator OTHER

  • Boston Children's Hospital

    lead OTHER

Principal Investigators

  • Sharon Levy, MD, MPH · Boston Children's Hospital

Eligibility

Min Age
12 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-21
Primary Completion
2022-02-25
Completion
2022-02-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04200339 on ClinicalTrials.gov